Cervical screening + STI Flashcards
Hx taking: DISCHARGE - Questions to ask?
- Colour
- Consistency
- Blood
- Duration
- Timing? cyclical/constant
- Odour
- Previous hx
- Sexual hx
- Menstrual hx
Hx taking: POST-COITAL BLEEDING - Questions to ask?
- Timing?
- Duration?
- Previous hx?
- IMB?
- Menstrual hx?
- Smear hx?
- Any other symptoms?
ABNORMAL discharge: Differential Diagnosis
- Physiological (3)
- Infective (non-sexually transmitted) (2)
- Infective (sexually transmitted) (4)
- Non-infective (6)
Physiological:
- Oestrogen related (puberty, pregnancy, COCP)
- Cycle related (max. mid cycle + premenstrual)
- Sexual excitement/intercourse
Infective (non-sexually transmitted):
- Bacterial vaginosis
- Candida
Infective (sexually transmitted):
- Chlamydia trachomatis
- Neisseria gonorrhoea
- Trichomonas vaginalis
- Herpes simplex virus
Non-infective:
- Foreign bodies (e.g. retained tampons, condoms)
- Cervical polyps and ectopy
- Genital tract malignancy
- Fistulae (urinary of faecal)
- Allergic reactions
- Atrophic vaginitis (often blood stained)
Large Loop Excision of the Transformation Zone (LLETZ): Definition
Removal of the transformation zone with a loop diathermy device, usually under local anaesthetic.
DYSKARYOSIS: Definition
- Abnormal epithelial cell which may be found in a cervical sample.
- Dyskaryosis is NOT a histological diagnosis.
- It often corresponds with CIN - however a smear cannot diagnose CIN.
- A biopsy must be taken to assess the depth of invasion and therefore grade of CIN.
- Around 1:20 women will have some form of abnormal smear.
- It is NOT cancer.
- Abnormal cells often return to normal cells on their own, but if left untreated, these changes may develop into cancer in the future.
CIN
Cervical intraepithelial neoplasia (CIN), also known as cervical dysplasia, is the abnormal growth of cells on the surface of the cervix that could potentially lead to cervical cancer.
STIs: Confidentiality
Confidentiality paramount:
- GUM notes are kept separate from hospital notes.
- Patient’s GP is not routinely informed of patients attendance
- This is a requirement defined by statute in the Veneral Disease Act of 1917.
- Assessment of competency should be undertaken if under 16 years old (Fraser competence)
Risk factors for STIs
- Multiple partners (>2 in last year)
- Concurrent partners
- Recent partner change (in last 3 months)
- Non-use of barrier protection
- STI in partner
- Other STI
- Younger age (<25 yrs)
- Involvement in the commercial sex industry
INCUBATION period - Testing for sexually transmitted infections
Test should be done at the time of presentation. Incubation period before tests for STIs become positive can give false negative after a single episode of sex:
- Bacterial STIs 10-14 days
- HIV/syphilis may be up to 3 months
CHLAMYDIA: Definition
- Most prevalent sexually transmitted infection in the UK.
- It is caused by Chlamydia trachomatis, an obligate intracellular pathogen.
- Approximately 1 in 10 young women in the UK have Chlamydia.
- The incubation period is around 7-21 days, although it should be remembered a large percentage of cases are asymptomatic.
CHLAMYDIA: Features
- Asymptomatic in around 70% of women and 50% of men
- Women: cervicitis (discharge, bleeding), dysuria
- Men: urethral discharge, dysuria
CHLAMYDIA: Potential complications
- Epididymitis
- Pelvic inflammatory disease
- Endometritis
- Increased incidence of ectopic pregnancies
- Infertility
- Reactive arthritis
- Perihepatitis (Fitz-Hugh-Curtis syndrome)
CHLAMYDIA: Investigations
- Traditional cell culture is no longer widely used
- Nuclear acid amplification tests (NAATs) are now the investigation of choice
- Urine (first void urine sample), vulvovaginal swab or cervical swab may be tested using the NAAT technique
- For women: the vulvovaginal swab is first-line
- For men: the urine test is first-line
- Chlamydia testing should be carried out two weeks after a possible exposure
CHLAMYDIA: Screening
- In England the National Chlamydia Screening Programme is open to all men and women aged 15-24 years
- The 2009 SIGN guidelines support this approach, suggesting screening all sexually active patients aged 15-24 years
- Relies heavily on opportunistic testing
HERPES simplex virus: Definition
- There are two strains of the herpes simplex virus (HSV) in humans: HSV-1 and HSV-2.
- Whilst it was previously thought HSV-1 accounted for oral lesions (cold sores) and HSV-2 for genital herpes it is now known there is considerable overlap
HERPES simplex virus: Features
- Primary infection: may present with a severe gingivostomatitis
- Cold sores
- Painful genital ulceration
HERPES simplex virus: Management
- Gingivostomatitis: oral aciclovir, chlorhexidine mouthwash
cold sores: topical aciclovir although the evidence base for this is modest - Genital herpes: oral aciclovir.
- Some patients with frequent exacerbations may benefit from longer term aciclovir.
HERPES simplex virus: Pregnancy
- Elective caesarean section at term is advised if a primary attack of herpes occurs during pregnancy at greater than 28 weeks gestation
- Women with recurrent herpes who are pregnant should be treated with suppressive therapy and be advised that the risk of transmission to their baby is low
GONORRHOEA: Definition
- Gonorrhoea is caused by the Gram-negative diplococcus Neisseria gonorrhoeae.
- Acute infection can occur on any mucous membrane surface, typically genitourinary but also rectum and pharynx.
- The incubation period of gonorrhoea is 2-5 days.
GONORRHOEA: Features
- Males: urethral discharge, dysuria
- Females: cervicitis e.g. leading to vaginal discharge
rectal and pharyngeal infection is usually asymptomatic.
Local complications that may develop include urethral strictures, epididymitis and salpingitis (hence may lead to infertility). Disseminated infection may occur.
GONORRHOEA: Microbiology
Immunisation is not possible and reinfection is common due to antigen variation of type IV pili (proteins which adhere to surfaces) and Opa proteins (surface proteins which bind to receptors on immune cells)
GONORRHOEA: Management
- Ciprofloxacin used to be the treatment of choice.
- However, there is increased resistance to ciprofloxacin (around 36% in the UK) and therefore cephalosporins are now more widely used
- There was a change in the 2019 British Society for Sexual Health and HIV (BASHH) guidelines.
- Previously the first-line treatment was IM ceftriaxone + oral azithromycin.
- The new first-line treatment is a single dose of IM ceftriaxone 1g (i.e. no longer add azithromycin).
- If sensitivities are known (and the organism is sensitive to ciprofloxacin) then a single dose of oral ciprofloxacin 500mg should be given if ceftriaxone is refused (e.g. needle-phobic) then oral cefixime 400mg (single dose) + oral azithromycin 2g (single dose) should be used.
SYPHILIS: Definition
- Syphilis is a sexually transmitted infection caused by the spirochaete Treponema pallidum.
- Infection is characterised by primary, secondary and tertiary stages.
- The incubation period is between 9-90 days.
SYPHILIS: Primary features
- Chancre - painless ulcer at the site of sexual contact
- Local non-tender lymphadenopathy
- Often not seen in women (the lesion may be on the cervix)
SYPHILIS: Secondary features
Occurs 6-10 weeks after primary infection:
- Systemic symptoms: fevers, lymphadenopathy
- Rash on trunk, palms and soles
- Buccal ‘snail track’ ulcers (30%)
- Condylomata lata (painless, warty lesions on the genitalia)
SYPHILIS: Tertiary features
- Gummas (granulomatous lesions of the skin and bones)
- Ascending aortic aneurysms
- General paralysis of the insane
- Tabes dorsalis
- Argyll-Robertson pupil
SYPHILIS: Congenital syphilis
- Blunted upper incisor teeth (Hutchinson’s teeth), ‘mulberry’ molars
- Rhagades (linear scars at the angle of the mouth)
- Keratitis
- Saber shins
- Saddle nose
- Deafness
SYPHILIS: Investigations
- Treponema pallidum is a very sensitive organism and cannot be grown on artificial media.
- The diagnosis is therefore usually based on clinical features, serology and microscopic examination of infected tissue
SYPHILIS: Management
- Intramuscular benzathine penicillin is the first-line management
- Alternatives: doxycycline
N.B. The Jarisch-Herxheimer reaction is sometimes seen following treatment - fever, rash, tachycardia after the first dose of antibiotic. No treatment is needed other than antipyretics if required